Prescribing
This page lists 178 references in the Main Healthy Skepticism Library relevant to Prescribing.
Click on the HSL (Health Skepticism Library) number for more details which may include an abstract or full text.
HSL6901
Carrie AG, Grymonpre RE, Blandford AA.
Impact of Residence on Prevalence and Intensity of Prescription Drug Use Among Older Adults (November).
Ann Pharmacother 2006 Oct 10
http://www.theannals.com/cgi/reprint/aph.1H338v1
HSL6538
Cuzzolin L, Atzei A, Fanos V.
Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety.
Expert Opin Drug Saf 2006 Sep 01;5(5):703-18
http://www.expertopin.com/doi/abs/10.1517/14740338.5.5.703
HSL6666
Carroll NV, Smith JC, Berringer RA, Oestreich GL.
Evaluation of an automated system for prior authorization: a COX-2 inhibitor example.
Am J Manag Care 2006 Sep 01;12(9):501-8
http://www.ajmc.com/Article.cfm?ID=3187&CFID=3768231&CFTOKEN=45537093
HSL6808
Wong IC, Basra N, Yeung VW, Cope J.
Supply problems of unlicensed and off-label medicines after discharge.
Arch Dis Child 2006 Aug 01;91(8):686-8
http://adc.bmjjournals.com/cgi/content/full/91/8/686
HSL6343
Sonntag A, Matschinger H, Angermeyer MC, Riedel-Heller SG.
Does the context matter? Utilization of sedative drugs in nursing homes - a multilevel analysis
Pharmacopsychiatry. 2006 Jul 01;39(4):142-9
http://www.thieme-connect.com/DOI/DOI?10.1055/s-2006-946704
HSL6805
Kesselheim AS, Fischer MA, Avorn J.
The rise and fall of Natrecor for congestive heart failure: implications for drug policy.
Health Aff (Millwood) 2006 Jul-Aug 01;25(4):1095-102
http://content.healthaffairs.org/cgi/content/full/25/4/1095
HSL5807
Sutcliffe AG, Wong IC.
Rational prescribing for children.
BMJ 2006 Jun 24;332(7556):1464-5
http://bmj.bmjjournals.com/cgi/content/full/332/7556/1464
HSL5808
Hagan P.
Four in five asthma deaths may be due to long acting beta agonists.
BMJ 2006 Jun 24;332(7556):1467
http://bmj.bmjjournals.com/cgi/content/extract/332/7556/1467-a
HSL5936
Andersen M, Kragstrup J, Sondergaard J.
How conducting a clinical trial affects physicians' guideline adherence and drug preferences.
JAMA 2006 Jun 21;295(23):2759-64
http://jama.ama-assn.org/cgi/content/full/295/23/2759
HSL5937
Psaty BM, Rennie D.
Clinical trial investigators and their prescribing patterns: another dimension to the relationship between physician investigators and the pharmaceutical industry.
JAMA 2006 Jun 21;295(23):2787-90
http://jama.ama-assn.org/cgi/content/full/295/23/2787
HSL5721
Tanne JH.
Antipsychotic use among US young people has risen sixfold.
BMJ 2006 Jun 17;332(7555):1407
http://bmj.bmjjournals.com/cgi/content/short/332/7555/1407?etoc
HSL5722
Eaton L.
European agency approves use of fluoxetine for children and teens.
BMJ 2006 Jun 17;332(7555):1407
http://bmj.bmjjournals.com/cgi/content/short/332/7555/1407-a?etoc
HSL5812
Reenan J.
Rx for physician prescribing practices
Virtual Mentor. 2006; 8: 2006 Jun 1;8(6):359-361
http://www.ama-assn.org/ama/pub/category/16249.html
HSL5813
Finkelstein JA.
Unnecessary antibiotics
Virtual Mentor: Ethics Journal of the American Medical Association 2006 Jun 1;8(6):362-366
http://www.ama-assn.org/ama/pub/category/16250.html
HSL5814
Adair R.
Hidden costs of free samples
Virtual Mentor: Ethics Journal of the American Medical Association 2006 Jun 1;8(6):367-371
http://www.ama-assn.org/ama/pub/category/16251.html
HSL5815
Sierles FS.
The gift-giving influence
Virtual Mentor: Ethics Journal of the American Medical Association 2006 Jun 1;8(6):372-376
http://www.ama-assn.org/ama/pub/category/16252.html
HSL5817
Ruiz JG, Hagenlocker B.
E-prescribing
Virtual Mentor: Ethics Journal of the American Medical Association 2006 Jun 1;8(6):381-386
http://www.ama-assn.org/ama/pub/category/16254.html
HSL6383
Livesey JE, Chiew YF.
Antimicrobial drug utilisation in Dunedin Hospital, New Zealand, and its association with antimicrobial resistance.
Pathology 2006 Jun 01;38(3):245-8
Link to source with long URL
HSL6614
Westerlund LT, Bjork HT.
Pharmaceutical care in community pharmacies: practice and research in Sweden.
Ann Pharmacother 2006 Jun 01;40(6):1162-9
http://www.theannals.com/cgi/content/full/40/6/1162
HSL5481
Hitchen L.
Adverse drug reactions result in 250,000 UK admissions a year.
BMJ 2006 May 13;332(7550):1109
http://bmj.bmjjournals.com/cgi/content/full/332/7550/1109
HSL5610
Radley DC, Finkelstein SN, Stafford RS.
Off-label prescribing among office-based physicians.
Arch Intern Med 2006 May 8;166(9):1021-6
http://archinte.ama-assn.org/cgi/content/full/166/9/1021
HSL6114
Ali MH, Kalima P, Maxwell SR.
Failure to implement hospital antimicrobial prescribing guidelines: a comparison of two UK academic centres.
J Antimicrob Chemother 2006 May 01;57(5):959-62
http://jac.oxfordjournals.org/cgi/content/full/57/5/959
HSL6210
Shiwani MH.
Quest of prescribing practice in Pakistan.
J Pak Med Assoc 2006 May 01;56(5):249-50
HSL5592
Rane A.
[Drug committees should not recommend 'off label' prescriptions].
Lakartidningen 2006 Apr 12-25;103(15-16):1219
HSL5589
Fossey J, Ballard C, Juszczak E, James I, Alder N, Jacoby R, Howard R.
Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial.
BMJ 2006 Apr 1;332(7544):756-61
http://bmj.bmjjournals.com/cgi/content/full/332/7544/756
HSL5980
Klein CA.
Dispensing pharmaceutical samples: a few reminders.
Nurse Pract 2006 Apr 01;31(4):15
Link to source with long URL
HSL5583
Bestehorn K, Voller H, Benecke H, Renner H, Karmann B, Wegscheider K.
Drug utilization of ezetimibe in rehabilitation centres: registry analysis of factors influencing prescription and effectiveness of treatment.
Curr Med Res Opin 2006 Apr;22(4):631-9
Link to source with long URL
HSL5630
Martin A.
Stimulating: prescribing amidst controversy.
Am J Psychiatry 2006 Apr;163(4):574-7
Link to source with long URL
HSL5368
Maclure M, Nguyen A, Carney G, Dormuth C, Roelants H, Ho K, Schneeweiss S.
Measuring prescribing improvements in pragmatic trials of educational tools for general practitioners.
Basic Clin Pharmacol Toxicol 2006 Mar;98(3):243-52
Link to source with long URL
HSL5090
Lenzer J.
US agency launches initiative on better prescribing for hypertension.
BMJ 2006 Feb 18;332(7538):379
http://bmj.bmjjournals.com/cgi/content/full/332/7538/379-a/DC1
HSL5425
Lasser KE, Seger DL, Yu DT, Karson AS, Fiskio JM, Seger AC, Shah NR, Gandhi TK, Rothschild JM, Bates DW.
Adherence to black box warnings for prescription medications in outpatients.
Arch Intern Med 2006 Feb 13;166(3):338-44
http://archinte.ama-assn.org/cgi/content/full/166/3/338
HSL5289
Flaten O.
[Are children getting the right drugs?]
Tidsskr Nor Laegeforen 2006 Feb 9;126(4):481 2006 Feb 9;126(4):481
http://www.tidsskriftet.no/pls/lts/pa_lt.visSeksjon?vp_SEKS_ID=1341354
HSL5495
Espino DV, Bazaldua OV, Palmer RF, Mouton CP, Parchman ML, Miles TP, Markides K.
Suboptimal medication use and mortality in an older adult community-based cohort: results from the Hispanic EPESE Study.
J Gerontol A Biol Sci Med Sci 2006 Feb;61(2):170-5
http://biomed.gerontologyjournals.org/cgi/content/full/61/2/170
HSL6340
Yoon EY, Davis MM, El-Essawi H, Cabana MD.
FDA labeling status of pediatric medications.
Clin Pediatr (Phila) 2006 Jan-Feb 01;45(1):75-7
HSL5959
Mitchell TB, Dyer KR, Peay ER.
Patient and physician characteristics in relation to clinical decision making in methadone maintenance treatment.
Subst Use Misuse 2006;41(3):393-404
Link to source with long URL
HSL6570
Datti B, Carter MW.
The effect of direct-to-consumer advertising on prescription drug use by older adults.
Drugs Aging 2006;23(1):71-81
HSL6787
Arden JD, Brensilver PC.
A bitter pill for plaintiffs: obstacles to market theories of causation in prescription drug consumer fraud cases.
Food Drug Law J 2006;61(3):539-46
HSL6974
Tonkin AL, Taverner D, Latte J, Doecke C.
The Effect of an Interactive Tutorial on the Prescribing Performance of Senior Medical Students
Med Educ. 2006
HSL4046
Brett AS, Zuger A.
The run on tamiflu--should physicians prescribe on demand?
N Engl J Med 2005 Dec 22;353(25):2636-7
Link to source with long URL
HSL4035
Huang F, Et AL.
The Association of Pharmaceutical Company Promotional Spending With Resident Physician Prescribing Behavior
Academic Psychiatry 2005 Dec 1(29):500-501
http://ap.psychiatryonline.org/cgi/content/full/29/5/500
HSL5295
Citrome L, Jaffe A, Levine J, Lindenmayer JP.
Dosing of quetiapine in schizophrenia: how clinical practice differs from registration studies.
J Clin Psychiatry 2005 Dec;66(12):1512-6
http://article.psychiatrist.com/?ContentType=START&ID=10002270
HSL5387
Sims C.
Off-label use of drugs remains a concern for anaesthetists caring for children.
Anaesth Intensive Care 2005 Dec;33(6):824
HSL5590
Zuckerman IH, Hernandez JJ, Gruber-Baldini AL, Hebel JR, Stuart B, Zimmerman S, Magaziner J.
Potentially inappropriate prescribing before and after nursing home admission among patients with and without dementia.
Am J Geriatr Pharmacother 2005 Dec;3(4):246-54
Link to source with long URL
HSL4223
Verdoux H, Cougnard A, Grolleau S, Begaud B.
Impact of visits from pharmaceutical company representatives on antipsychotic prescription in primary care.
Schizophr Res 2005 Sep 1;77(1):107-9
http://linkinghub.elsevier.com/retrieve/pii/S0920-9964(05)00066-6
HSL5858
Bell DS, Friedman MA.
E-prescribing and the medicare modernization act of 2003. Paving the on-ramp to fully integrated health information technology?
Health Aff (Millwood) 2005 Sep-Oct 01;24(5):1159-69
http://content.healthaffairs.org/cgi/content/full/24/5/1159
HSL5575
Pandolfini C, Bonati M.
A literature review on off-label drug use in children.
Eur J Pediatr 2005 Sep;164(9):552-8
HSL4177
Miller FG, Wendler D.
Direct-to-consumer advertising and physician prescribing.
JAMA 2005 Aug 10;294(6):678
http://jama.ama-assn.org/cgi/content/full/294/6/678
HSL5681
Izzo JL Jr.
Your drug, my drug, or our drugs: how aggressive should we be with antihypertensive therapy?
J Clin Hypertens (Greenwich) 2005 Aug 01;7(8)
Link to source with long URL
HSL2487
Maxwell SR.
Evidence based prescribing.
BMJ 2005 Jul 30;331(7511):247-8
http://bmj.bmjjournals.com/cgi/content/full/331/7511/247
HSL5890
Miller RA, Gardner RM, Johnson KB, Hripcsak G.
Clinical decision support and electronic prescribing systems: a time for responsible thought and action.
J Am Med Inform Assoc 2005 Jul-Aug 01;12(4):403-9
http://www.jamia.org/cgi/content/full/12/4/403
HSL1978
Stocks N, Allan J, Mansfield PR.
Management of hyperlipidaemia.
Aust Fam Physician 2005 Jun;34(6):447-53
http://www.racgp.org.au/document.asp?id=17049
HSL4047
Direct-to-consumer advertising: impact on prescribing.
Child Health Alert 2005 Jun;24:5-6
Link to source with long URL
HSL4058
Bateman C.
Government 'encouraging snake-oil salesman' Rath.
S Afr Med J 2005 Jun 01;95(6):372,
Link to source with long URL
HSL4240
Jackson G.
Generic prescribing -- the chaos continues.
Int J Clin Pract 2005 Jun 01;59(6):618
Link to source with long URL
HSL2473
Pouye A, Dia D, Sow PS, Yacouba H, Ndour CT, Soumare M, Ciss M, Moreira Diop T.
[Prescription of morphinics in the management of pain in Dakar teaching hospitals]
Bull Soc Pathol Exot. 2005 Jun;98(2):118-20
Nil
HSL1876
Pringle E.
Bush-Backed Drug Marketing Schemes
The Sierra Time 2005 Apr 26
HSL2478
De Conno F, Ripamonti C, Brunelli C.
Opioid purchases and expenditure in nine western European countries: are we killing off morphine?
Palliat Med. 2005 Apr;19(3):179-84
Link to source with long URL
HSL5396
Shatin D, Gardner JS, Stergachis A, Blough D, Graham D.
Impact of mailed warning to prescribers on the co-prescription of tramadol and antidepressants.
Pharmacoepidemiol Drug Saf 2005 Mar;14(3):149-54
Link to source with long URL
HSL5893
Nikles CJ, Clavarino AM, Del Mar CB.
Using n-of-1 trials as a clinical tool to improve prescribing.
Br J Gen Pract 2005 Mar;55(512):175-80
Link to source with long URL
HSL1218
Lexchin J.
Prescribing errors
CMAJ 2005 Jan 18;172(2)
http://www.cmaj.ca/cgi/content/full/172/2/229
HSL5468
Rataboli PV, Garg A.
Confusing brand names: nightmare of medical profession.
J Postgrad Med 2005 Jan-Mar;51(1):13-6
Link to source with long URL
HSL2715
Muijrers P, Grol R., Sijbrandij J, Janknegt R., Knottnerus J
Differences in prescribing between general practitioners.
Unpublished 2005
Nil
HSL5983
Campo K, De Staebel O, Gijsbrechts E, van Waterschoot W.
Physicians' decision process for drug prescription and the impact of pharmaceutical marketing mix instruments.
Health Mark Q 2005;22(4):73-107
HSL6407
Lambert BL, Lin SJ, Tan H.
Designing safe drug names.
Drug Saf 2005;28(6):495-512
HSL2214
Fitzgerald MA.
Appropriate antibiotic prescribing. Guidance for the use of drug samples
Adv Nurse Pract. 2004 Dec 01;12(12):18-22
HSL5844
Muijrers PE, Janknegt R, Sijbrandij J, Grol RP, Knottnerus JA.
Prescribing indicators. Development and validation of guideline-based prescribing indicators as an instrument to measure the variation in the prescribing behaviour of general practitioners.
Eur J Clin Pharmacol 2004 Dec 01;60(10):739-46
Link to source with long URL
HSL5960
Dybdahl T, Andersen M, Sondergaard J, Kragstrup J, Kristiansen IS.
Does the early adopter of drugs exist ? A population-based study of general practitioners' prescribing of new drugs.
Eur J Clin Pharmacol 2004 Nov 01;60(9):667-72
Link to source with long URL
HSL2079
Caudill-Slosberg MA, Schwartz LM, Woloshin S.
Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs 2000.
Pain 2004 Jun;109(3):514-9
http://linkinghub.elsevier.com/retrieve/pii/S0304395904001307
HSL296
Goulding MR.
Inappropriate medication prescribing for elderly ambulatory care patients.
Arch Intern Med 2004 Feb 9;164(3):305-12
http://archinte.ama-assn.org/cgi/content/full/164/3/305
HSL301
Morgan S.
Sources of variation in provincial drug spending.
CMAJ 2004 Feb 3;170(3):329-30
http://www.cmaj.ca/cgi/content/full/170/3/329
HSL2724
Stafford RS, Furberg CD, Finkelstein SN, Cockburn IM, Alehegn T, Ma J.
Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002.
JAMA 2004 Jan 7;291(1):54-62
http://jama.ama-assn.org/cgi/content/full/291/1/54
HSL5857
Bell DS, Cretin S, Marken RS, Landman AB.
A conceptual framework for evaluating outpatient electronic prescribing systems based on their functional capabilities.
J Am Med Inform Assoc 2004 Jan-Feb 01;11(1):60-70
http://www.jamia.org/cgi/content/full/11/1/60
HSL2719
Prosser H, Walley T.
New drug uptake: qualitative comparison of high and low prescribing GPs' attitudes and approach.
Fam Pract 2003 Oct;20(5):583-91
http://fampra.oxfordjournals.org/cgi/content/full/20/5/583
HSL2240
Mintzes B, Barer ML, Kravitz RL, Bassett K, Lexchin J, Kazanjian A, Evans RG, Pan R, Marion SA.
How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA
CMAJ. 2003 Sep 2;169(5):405-12
http://www.cmaj.ca/cgi/content/full/169/5/405
HSL5873
Finkelstein JA, Stille C, Nordin J, Davis R, Raebel MA, Roblin D, Go AS, Smith D, Johnson CC, Kleinman K, Chan KA, Platt R.
Reduction in antibiotic use among US children, 1996-2000.
Pediatrics 2003 Sep 01;112(3)
http://pediatrics.aappublications.org/cgi/content/full/112/3/620
HSL2725
Tamblyn R, McLeod P, Hanley JA, Girard N, Hurley J.
Physician and practice characteristics associated with the early utilization of new prescription drugs.
Med Care 2003 Aug;41(8):895-908
Link to source with long URL
HSL5882
Kaushal R, Shojania KG, Bates DW.
Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review.
Arch Intern Med 2003 Jun 23;163(12):1409-16
http://archinte.ama-assn.org/cgi/content/full/163/12/1409
HSL1425
Kocs D, Fendrick AM.
Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experience.
Am J Manag Care 2003 May;9(5):393-400
http://www.ajmc.com/files/articlefiles/AJMC2003mayKocsCPE393-402.pdf
HSL2441
Prosser H, Almond S, Walley T.
Influences on GPs' decision to prescribe new drugs-the importance of who says what.
Fam Pract 2003 Feb;20(1):61-8
http://fampra.oxfordjournals.org/cgi/content/full/20/1/61
HSL5957
Helgason T, Tomasson K, Zoega T.
[Prevalence and distribution of antidepressant, anxiolytic and hypnotic use in 2001].
Laeknabladid 2003 Jan 01;89(1):15-22
HSL6145
Russell FM, Shann F, Curtis N, Mulholland K.
Evidence on the use of paracetamol in febrile children.
Bull World Health Organ 2003;81(5):367-72
Link to source with long URL
HSL2902
Bessell TL, Silagy CA, Anderson JN, Hiller JE, Sansom LN.
Quality of global e-pharmacies: can we safeguard consumers?
Eur J Clin Pharmacol 2002 Dec;58(9):567-72
Link to source with long URL
HSL2899
Boltri JM, Gordon ER, Vogel RL.
Effect of antihypertensive samples on physician prescribing patterns.
Fam Med 2002 Nov-Dec;34(10):729-31
Link to source with long URL
HSL2868
Haugh R, Thrall TH, Scalise D.
Prescription for concern.
Hosp Health Netw 2002 Feb;76(2):44-9
Link to source with long URL
HSL1483
Zachry WM 3rd, Shepherd MD, Hinich MJ, Wilson JP, Brown CM, Lawson KA.
Relationship between direct-to-consumer advertising and physician diagnosing and prescribing.
Am J Health Syst Pharm 2002 Jan 1;59(1):42-9
http://www.ajhp.org/cgi/reprint/59/1/42
HSL5921
Steinman MA, Sands LP, Covinsky KE.
Self-restriction of medications due to cost in seniors without prescription coverage.
J Gen Intern Med 2001 Dec;16(12):793-9
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1525-1497.2001.10412.x
HSL2720
Schwartz TL, Kuhles DJ 2nd, Wade M, Masand PS.
Newly admitted psychiatric patient prescriptions and pharmaceutical sales visits.
Ann Clin Psychiatry 2001 Sep;13(3):159-62
Link to source with long URL
HSL2695
Gonul F, Carter F, Petrova E, Srinivasan K.
Promotion of Prescription Drugs and its impact on Physicians’ Choice Behaviour
Journal of Marketing 2001 Jul;65:79-90
Nil
HSL8521
Jackimiec JM.
Communicating utilization and critical issues to health providers
ASHP Annual Meeting 2001 Jun;58
HSL2962
Meek C.
2001
www.rpsgb.org.uk/pdfs/dtcarep.pdf
HSL1659
Jureidini JN.
Epidemic of schizophrenia in children or inappropriate prescribing?
Med J Aust 2000 Nov 20;173(10):555-6
HSL2164
Pearson S, Smith AJ, Rolfe IE, Moulds RF, Shenfield GM.
Intern Prescribing for Common Clinical Conditions.
Adv Health Sci Educ Theory Pract 2000;5(2):141-150
Link to source with long URL
HSL2158
Jackson C, Mcguire T, Dommers E, Nyst P.
A GP prescribing educational intervention involving a medication panel.
Aust Fam Physician 1999 Nov;28(11):1191-5
HSL2692
Dolovich L, Levine M, Tarajos R, Duku E.
Promoting optimal antibiotic therapy for otitis media using commercially sponsored evidence-based detailing: A prospective controlled trial.
Drug Information Journal 1999;33(4):1067-1077
Link to source with long URL
HSL550
Collier J.
Patient-information leaflets and prescriber competence.
Lancet 1998 Nov 28;352(9142):1724
Link to source with long URL
HSL5918
Schiff GD, Rucker TD.
Computerized prescribing: building the electronic infrastructure for better medication usage.
JAMA 1998 Apr 1;279(13):1024-9
http://jama.ama-assn.org/cgi/content/full/279/13/1024
HSL533
Lexchin J.
Improving the appropriateness of physician prescribing.
Int J Health Serv 1998;28(2):253-67
Nil
HSL743
Wolfe S.
Drug advertisements and prescribing
Lancet 1997;348:1452-1453
HSL776
Landefeld CS, Chren MM.
Drug companies and information about drugs: recommendations for doctors. Characteristics of materials distributed by drug companies: four points of view
J Gen Intern Med 1996 Oct 01;11(10):642-4
HSL805
Anderson GM, Lexchin J.
Strategies for improving prescribing practice.
CMAJ 1996 Apr 1;154(7):1013-7
http://www.cma.ca/cmaj/vol-154/1013e.htm
HSL2723
Spingarn RW, Berlin JA, Strom BL.
When pharmaceutical manufacturers' employees present grand rounds, what do residents remember?
Acad Med 1996 Jan;71(1):86-8
Link to source with long URL
HSL759
Shear NH, Black F, Lexchin J.
Examining the physician-detailer interaction
Can J Clin Pharmacol 1996;3(4):175-179
HSL791
Gilbert D, Chetley A.
New trends in drug promotion
Consumer Policy Review 1996;63(5):162-167
HSL809
Aldir RE, Jarjoura D, Phinney M, Poordad F, Gutierrez R, Marnejon T, Greifenstein E, Lappin J, Whittier FC.
Practicing and resident physician’s views on pharmaceutical companies.
J Contin Educ Health Prof 1996;16:25-32
HSL1709
Cárdenas EZ, Isenrich LL.
Prescribing habits of Peruvian physicians and factors influencing them
Bulletin of PAHO 1995;29:328-337
HSL2160
Ekedahl A, Andersson SI, Hovelius B, Molstad S, Liedholm H, Melander A.
Drug prescription attitudes and behaviour of general practitioners. Effects of a problem-oriented educational programme
Eur J Clin Pharmacol 1995;47(5):381-7
HSL5878
Guell RC, Fischbaum M.
Toward allocative efficiency in the prescription drug industry.
Milbank Q 1995;73(2):213-30
HSL5696
Lexchin J.
Physicians and drug companies interact.
Can Fam Physician 1993 Sep 01;39:1881-2
HSL5551
Leppard W, Ogletree SM, Wallen E.
Gender stereotyping in medical advertising: much ado about something?
Sex Roles 1993;29:829-838
HSL5140
Ukens C.
Consumer advertising found to pack prescribing punch
Drug Topics 1992 Nov 9;136(21):24, 26
HSL4988
Chetley A.
Promoting health or pushing drugs?
HAI News 1992 Oct(67):1-2, 10-12
HSL4936
Wivell MK, O’fallon DA.
Drug overpromotion: when is a warning not a warning?
Trial 1992;28(11):20-27
HSL4712
Taylor RJ, Bond CM.
Change in the established prescribing habits of general practitioners: an analysis of initial prescriptions in general practice
British Journal of General Practice 1991;41:244-248
HSL4500
Ahmad SR, Bhutta ZA.
A survey of pediatric prescribing and dispensing in Karachi
Journal of the Pakistan Medical Association 1990;40:126-130
HSL4548
Lexchin J.
The portrayal of the elderly in drug advertisements: a factor in inappropriate prescribing?
Canadian Journal on Aging 1990;9:296-303
HSL4549
Lexchin J.
Prescribing by Canadian general practitioners: review of the English language literature
Canadian Family Physician 1990;36:465-470
HSL4113
Harvey K.
What influences prescribing--scientific articles or promotional pressure?
Med J Aust 1988 Dec 5-19;149(11-12):720
HSL2198
Bowman MA, Pearle DL.
Changes in drug prescribing patterns related to commercial company funding of continuing medical education.
J Contin Educ Health Prof 1988;8(1):13-20
HSL4000
Harvey K.
The influence of advertising over prescribing
Australian Journal of Hospital Pharmacy 1988;18(3):25-28
HSL4004
Hemminki E.
Commercial information on drugs: confusing the physician?
Journal of Drug Issues 1988;18:245-257
HSL4017
Lexchin J.
Pharmaceutical promotion in New Zealand.
Community Health Stud 1988;12(3):264-72
HSL4031
Peay MY, Peay ER.
The role of commercial sources in the adoption of a new drug.
Soc Sci Med 1988;26(12):1183-9
Link to source with long URL
HSL4032
Pitt L, Nel D.
Pharmaceutical promotion tools—their relative importance
European Journal of Marketing 1988;22:7-14
HSL4072
Tan M.
Dying for drugs: pill power and politics in the Philippines
1988
HSL2722
Soumerai SB, Avorn J, Gortmaker S, Hawley S.
Effect of government and commercial warnings on reducing prescription misuse: the case of propoxyphene.
Am J Public Health 1987 Dec;77(12):1518-23
Link to source with long URL
HSL3886
Hardy AJ.
Drug promotion.
N Z Med J 1987 Oct 28;100(834):667
HSL3902
Lexchin J.
Drug promotion.
N Z Med J 1987 Sep 23;100(832):603
HSL3772
Carter IE.
Canadian Psychiatric Association guidelines in relating to the pharmaceutical industry.
Can J Psychiatry 1987 Aug;32(6):476-86
http://www.cpa-apc.org/Publications/Position_Papers/Guideline.asp
HSL3868
Bower AD, Burkett GL.
Family physicians and generic drugs: a study of recognition, information sources, prescribing attitudes, and practices.
J Fam Pract 1987 Jun;24(6):612-6
HSL3927
Wells F.
Promotion by the drug companies--the industry replies.
J R Coll Gen Pract 1987 Jun;37(299):270
HSL3906
Marks I, Mathews A.
Treatment for panic.
Lancet 1987 Apr 4;1(8536):805
HSL3883
Greenhalgh T.
Drug prescription and self-medication in India: an exploratory survey.
Soc Sci Med 1987;25(3):307-18
HSL3903
Lexchin J.
Pharmaceutical promotion in Canada: convince them or confuse them.
Int J Health Serv 1987;17(1):77-89
HSL3905
Mahady JM.
Frequent-flyer programs for drug prescribing
New England Journal of Medicine 1987;317:252
HSL3908
Palmer WH, Ross DL.
Introducing a new drug into your practice
Canadian Family Physician 1987;33:2529-2533
HSL3921
Szuba TJ.
Drug promotion under the magnifying glass
Journal of Social and Administrative Pharmacy 1987;4:77-80
HSL3851
Greenhalgh T.
Beneath cosmetic reforms
HAI News 1986 Oct
HSL3783
Greenhalgh T.
Drug marketing in the Third World: beneath the cosmetic reforms.
Lancet 1986 Jun 7;1(8493):1318-20
HSL3749
Morris LA, Ruffner M, Klimberg , R .
Warning disclosures for prescription drugs
Journal of Advertising Research 1985 Oct-Nov;25(2):25-32
HSL3739
Kunin CM.
The responsibility of the infectious disease community for the optimal use of antimicrobial agents.
J Infect Dis 1985 Mar;151(3):388-98
HSL3718
Krupka LR, Vener AM.
Prescription drug advertising: trends and implications.
Soc Sci Med 1985;20(3):191-7
HSL3731
Putnam RW, Fox RD, Mazmanian PE.
Report to Pharmaceutical Manufacturers Association of Canada: an analysis of drug prescribing changes by physicians
1985
HSL3664
Yudkin JS.
Use and misuse of drugs in the Third World.
Dan Med Bull 1984 Nov;31
HSL3633
Henderson IWD.
Pharmaceutical advertising in medical journals
Canadian Medical Association Journal 1984;131:546
HSL3638
Laporte JR, Porta M, Capella D, Arnau JM.
Drugs in the Spanish health system.
Int J Health Serv 1984;14(4):635-48
HSL3594
Smith MC.
An analysis of the impact of print advertising on prescribing
1983:259-278
HSL2425
Avorn J, Chen M, Hartley R.
Scientific versus commercial sources of influence on the prescribing behavior of physicians.
Am J Med 1982 Jul;73(1):4-8
Nil
HSL3558
Strickland-Hodge B, Jepson MH.
Identification and characterization of early and late prescribers in general practice.
J R Soc Med 1982 May;75(5):341-5
HSL3538
Cooperstock R, Hill J.
The effects of tranquillization: benzodiazepine use in Canada
Health and Welfare Canada 1982
HSL3560
Victora CG.
Statistical malpractice in drug promotion: a case-study from Brazil.
Soc Sci Med 1982;16(6):707-9
HSL3498
Christensen DB, Bush PJ.
Drug prescribing: patterns, problems and proposals.
Soc Sci Med [A] 1981 May;15(3)
HSL3509
Gustafsson LL, Wide K.
Marketing of obsolete antibiotics in Central America.
Lancet 1981 Jan 3;1(8210):31-3
HSL3492
Siskind V.
Prescription drug advertising
Medical Journal of Australia 1980 Jun 14;67:615, 617
HSL3473
Johnston TS.
Provision of medicines in Ecuador.
Lancet 1980 May 17;1(8177):1073-4
HSL3489
Babich F, Moore J.
Prescription drug advertising
Medical Journal of Australia 1980 Mar 22;67:282
HSL3488
Bell RW, Osterman J.
The Compendium of Pharmaceuticals and Specialties: a critical analysis
1980 Mar:19
HSL3487
Yudkin JS.
The economics of pharmaceutical supply in Tanzania.
Int J Health Serv 1980;10(3):455-77
HSL3390
Green B.
The politics of psychoactive drug use in old age.
Gerontologist 1978 Dec;18(6):525-30
HSL2691
Dajda R.
Drug advertising and prescribing.
J R Coll Gen Pract 1978 Sep;28(194):538-41
Link to source with long URL
HSL3391
Harrell GD, Lindsay CM.
Pharmaceutical marketing
1978:69-90
HSL3383
Cocking C.
The abuse of prescription drugs
Weekend Magazine 1977 Jun 18:16-19
HSL2505
Mapes R.
Aspects of British general practitioners' prescribing.
Med Care 1977 May;15(5):371-81
Nil
HSL3378
Waldron I.
Increased prescribing of Valium, Librium, and other drugs--an example of the influence of economic and social factors on the practice of medicine.
Int J Health Serv 1977;7(1):37-62
HSL3295
Achong MR.
Use of cephalosporins.
Can Med Assoc J 1976 Nov 6;115(9):841
HSL3304
Hemminki E.
Factors influencing drug prescribing--inquiry into research strategy.
Drug Intell Clin Pharm 1976 Jun;10(6):321-9
HSL3316
Silverman M, Lee PR.
Pills, profits & politics
University of California Press 1976
HSL3335
Halberstam M.
The other side of the coin: another physician views drug advertising
Journal of Drug Issues 1976;6(1):9-12
HSL3339
Pekkanen J.
The impact of promotion on physicians' prescribing patterns
Journal of Drug Issues 1976;6(1):13-20
HSL3343
Stetler CJ.
Advertising of prescription medicines.
Journal of Drug Issues 1976;6(1):34-42
HSL3241
Hemminki E.
The effect of a doctor's personal characteristics and working circumstances on the prescribing of psychotropic drugs.
Med Care 1974 Apr;12(4):351-7
HSL3246
Miller RR.
Prescribing habits of physicians: a review of studies on prescribing of drugs. Parts VII-Viii
Drug Intelligence and Clinical Pharmacy 1974;8:81-91
HSL3264
Penna RD.
American Pharmaceutical Association
Journal of Drug Issues 1974;4:268-273
HSL3230
Worthen DB.
Prescribing influences: an overview.
Br J Med Educ 1973 Jun;7(2):109-17
HSL3225
Miller RR.
Prescribing habits of physicians: a review of studies on prescribing of drugs. Parts IV-VI
Drug Intelligence and Clinical Pharmacy 1973;7:557-564
HSL3233
Stetler CJ.
Patterns of prescription drug use: The role of promotion
Journal of Drug Education 1973;3(4):389-402
HSL2687
Becker MH, Stolley PD, Lasagna L, McEvilla JD, Sloane LM.
Characteristics and attitudes of physicians associated with the prescribing of chloramphenicol.
HSMHA Health Rep 1971 Nov;86(11):993-1003
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB=pubmed
HSL3174
Hammel RW.
Physician evaluation of pharmaceutical manufacturers and their detailmen: How it effects their prescribing
Medical Marketing & Media 1970 Oct;5(10):7-8, 10, 12, 14
HSL2415
Talalay P, Editor.
Drugs in Our Society.
Baltimore: John Hopkins Press; 1964
Link to source with long URL